Are Triumeq and Biktarvy the Same Thing?
Triumeq (abacavir, dolutegravir, and lamivudine) and Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) are combinations of an integrase strand transfer inhibitor (INSTI) and two HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs) used to treat human immunodeficiency virus type 1 (HIV1) infection.
Side effects of Triumeq that are different from Biktarvy include vomiting, fever, loss of appetite, low energy, abnormal body fat distribution, numbness and tingling, hypersensitivity reactions (fever, rash, shortness of breath, cough, or sore throat), joint pain or swelling, muscle pain, extremity swelling, depression, and spinning sensation (vertigo).
Both Triumeq and Biktarvy may interact with other medicines to treat HIV or AIDS, dofetilide, antacids or laxatives that contain aluminum or magnesium (Maalox, Milk of Magnesia, Mylanta, Pepcid Complete, Rolaids, and others), vitamin or mineral supplements that contain calcium or iron, St. John's wort, and medicines that contain metformin.
Triumeq may also interact with sucralfate, buffered medicines, and dalfampridine.
Biktarvy may also interact with anticonvulsants, antimycobacterials, acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple nonsteroidal anti-inflammatory drugs (NSAIDs).
What Are Possible Side Effects of Triumeq?
Common side effects of Triumeq include:
- loss of appetite,
- low energy,
- nightmares or abnormal dreams,
- abnormal body fat distribution,
- numbness and tingling,
- hypersensitivity reactions (fever, rash, shortness of breath, cough, or sore throat),
- joint pain or swelling,
- muscle pain,
- extremity swelling,
- dizziness, and
- spinning sensation (vertigo).
What Is Triumeq?
Triumeq may interact with dofetilide and other drugs. Tell your doctor all medications and supplements you use.
What Is Biktarvy?
Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) is a three-drug combination of a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), and two HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated as a complete regimen for the treatment of HIV-1 infection in adults who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 3 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Biktarvy.
What Drugs Interact With Triumeq?
Triumeq may interact with dexamethasone, imatinib, isoniazid, nefazodone, St. John's wort, antibiotics, antifungals, barbiturates, heart or blood pressure medications, HIV/AIDS medicines, medicines to treat narcolepsy, medications to treat osteoporosis or Paget's disease of bone, seizure medications, or grapefruit and grapefruit juice. Tell your doctor all medications and supplements you use.
What Drugs Interact With Biktarvy?
Biktarvy may interact with other antiretroviral medications, dofetilide, anticonvulsants, antimycobacterials, St John's wort, antacids containing aluminum or magnesium, supplements containing calcium or iron, metformin, acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple nonsteroidal anti-inflammatory drugs (NSAIDs). Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Biktarvy; it is unknown how it would affect a fetus. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Biktarvy during pregnancy. Because of the potential for HIV transmission, breastfeeding while using Biktarvy is not recommended.
How Should Triumeq be Taken?
The adult dose of Triumeq is one tablet daily.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Gilead. Biktarvy Product Information.